Misbah Tahir
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Misbah Tahir is currently Chief Financial & Accounting Officer at Maze Therapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at IGM Biosciences, Inc. from 2019 to 2025.
Previously, was Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Stephen M.
Ross School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Directeur Financier/CFO | 02/09/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| IGM BIOSCIENCES, INC. | Directeur Financier/CFO | 01/08/2025 |
| DERMIRA, INC. | Corporate Officer/Principal | 01/12/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
IGM Biosciences, Inc.
IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national